Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2003
10/16/2003WO2003033540A3 Starch
10/16/2003WO2003031613A3 Regulation of translation of heterologously expressed genes
10/16/2003WO2003029434A3 Novel molecules of the hkid-1-related protein family and uses thereof
10/16/2003WO2003029426A3 Human and murine cytokine polypeptides
10/16/2003WO2003029413A3 A novel g protein-coupled receptor, gave 10
10/16/2003WO2003027639A3 Glucocorticoid receptor nuclear translocation domain
10/16/2003WO2003027309A3 Diagnostic probe detection system
10/16/2003WO2003027295A3 Methods for diagnosis and treatment of diseases associated with altered expression of jak1
10/16/2003WO2003027231A3 Polynucleotide encoding adapter protein, pmn29
10/16/2003WO2003025540A3 Differential tagging of polymers for high resolution linear analysis
10/16/2003WO2003025127A3 Chromogenic in situ hybridization methods, kits, and compositions
10/16/2003WO2003023034A3 Regulation of human tau-tubulin kinase
10/16/2003WO2003016552A3 Dna purification and recovery from high particulate and solids samples
10/16/2003WO2003016525A9 Process for producing alcohol from starch
10/16/2003WO2003016496A3 Zinc finger binding domains for cnn
10/16/2003WO2003016472A3 Hybrid interferon/interferon tau proteins, compositions and methods of use
10/16/2003WO2003015707A3 Method for treating lung cancers
10/16/2003WO2003014391A3 Method for the detection of a polymorphism in cpb2
10/16/2003WO2003014359A3 A fusion protein
10/16/2003WO2003014077A3 Crystal forms and mutants of rank ligand
10/16/2003WO2003012394A3 Androgen receptor knock-out transgenic animals
10/16/2003WO2003012127A3 Assay for identifying inhibitors of hiv rt dimerization
10/16/2003WO2003012042A3 Ratio-based oligonucleotide probe selection
10/16/2003WO2003011907A3 Receptor, the use thereof, and mouse antibodies
10/16/2003WO2003011211A3 Peg-modified uricase
10/16/2003WO2003010288A3 Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same
10/16/2003WO2003010192A3 An inducer of apoptosis
10/16/2003WO2003009806A3 Methods for evaluating pathologic conditions using extracellular rna
10/16/2003WO2003008586A3 Engineering oncolytic viruses
10/16/2003WO2003005036A3 Epf receptor assays, compounds and therapeutic compositions
10/16/2003WO2003004704A3 Method of selecting dna sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity
10/16/2003WO2003004520A3 Mycobacterial antigens expressed during latency
10/16/2003WO2003002716A3 Polymer stabilized proteinases
10/16/2003WO2003002709A3 Novel technology for genetic mapping
10/16/2003WO2003001902A3 Alteration of oil traits in plants
10/16/2003WO2003000930A3 Nucleotide sequences involved in plant disease resistance
10/16/2003WO2003000923A3 Maternal effect gametophyte regulatory polynucleotide
10/16/2003WO2003000405A3 Biochips comprising nucleic acid/protein conjugates
10/16/2003WO2002102841A3 Identification and cloning of the receptor gene for symbiotic nitrogen fixation
10/16/2003WO2002102840A3 Multiners of class i major histocompatibility complexes cantaining modified beta2-microglobulin proteins
10/16/2003WO2002101050A3 Process for the preparation of d-pantothenic acid and/or salts thereof
10/16/2003WO2002099043A3 P5CRS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
10/16/2003WO2002098899A3 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
10/16/2003WO2002097043A3 Wnv core protein/capsid interacting protein and uses of the same
10/16/2003WO2002093176A3 Methods for identifying compounds for treatment of ibd
10/16/2003WO2002092024A3 Compounds and methods for inhibiting axillary malodour
10/16/2003WO2002090493A3 Δ4-desaturase genes and uses thereof
10/16/2003WO2002088081A3 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
10/16/2003WO2002086158A3 Method to analyse the kit genotype of pigs
10/16/2003WO2002077211A3 A virus (cryptovirus) within the rubulavirus genus and uses therefor
10/16/2003WO2002070684A3 Gene library for screening methods
10/16/2003WO2002070655A3 Mouse cytokine receptor
10/16/2003WO2002068680A3 Compositions and methods for regulating endogenous inhibitor of atp synthase, including treatment for diabetes
10/16/2003WO2002068677A8 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer
10/16/2003WO2002062821A8 Peptide or protein microassay method and apparatus
10/16/2003WO2002061104A3 Hybrid adenoviral vector
10/16/2003WO2002061089A3 Crystallized hnf4 gamma ligand binding domain polypeptide and screening methods employing same
10/16/2003WO2002060941A9 Fluorescent proteins
10/16/2003WO2002057495A3 A modeling framework for predicting the number, type, and distribution of crossovers in directed evolution experiments
10/16/2003WO2002054064A3 Method for screening for progesterone receptor isoform-specific ligands
10/16/2003WO2002044384A3 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
10/16/2003WO2002038588A3 Putrescine-n-methyltransferase promoter
10/16/2003WO2002032954A3 Phosphorylation modifications of apoptin
10/16/2003WO2002031189A3 Model system for the vivo study of apoptosis
10/16/2003WO2002029074A3 Genetic immunisation against cervical carcinoma
10/16/2003WO2002022778A3 Ab initio physics-based gene identification method
10/16/2003WO2002018631A3 Diagnosis of illnesses or predisposition to certain illnesses
10/16/2003WO2002008442A3 Means and methods for raising antibody concentration in compartments of the body of a non human animal
10/16/2003WO2002004680A3 Real-time sequence determination
10/16/2003WO2002002637A3 G-protein coupled receptors and nucleic acids encoding same
10/16/2003WO2001088148A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/16/2003WO2001077356A3 Protein kinase stress-related proteins and methods of use in plants
10/16/2003US20030196232 Regenerable portion thereof, a hybrid or later generation whose petals, leaves or both contain an enhanced ratio of one or more carotenoid compounds relative to lutein
10/16/2003US20030196219 Involves storing the Agrobacterium in the cold for some period of time so as to increase transformation efficiency
10/16/2003US20030196218 Improving existing lines of plants and development of new lines having desired traits by making a specific alteration of a specific pre-existing gene of a plant
10/16/2003US20030196217 Desaturase genes, enzymes encoded thereby, and uses thereof
10/16/2003US20030196216 Modifying resistance of plants to disease and/or pests, by using the caffeic acid O-methyltransferase (OMT) gene to modify lignin biosynthesis in plants
10/16/2003US20030196215 Novel class of proteins and uses thereof for plant resistance to various pathogenic agents
10/16/2003US20030196214 Isolating mRNA from plant growing both under normal and drought conditions, reverse transcripting mRNAs to cDNA, transferring genes into plants; genes obtained from cell differentiation in different conditions
10/16/2003US20030195349 H. pylori flbA polypeptides, immunogenic and vaccinating compositions comprising H. pylori flbA polypeptides, and compositions for detection of an infection comprising H. pylori flbA polypeptides
10/16/2003US20030195348 CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection
10/16/2003US20030195346 An isolated amino acid sequences are expressed by a cell; for use as human secreted proteins such as human insulin, interferon, Factor VIII, human growth hormones
10/16/2003US20030195338 Concatameric immunoadhesion
10/16/2003US20030195337 UL16 binding protein 4
10/16/2003US20030195336 Nucleic acid and polypeptide compositions encoding lepidopteran-toxic polypeptides
10/16/2003US20030195247 Antagonists of protein tryosin phosphatase 1B (PTP-1B) and T-cell protein tyrosine phosphatase (TC-PTP), used as antidiabetic agents and for prophylaxis of insulin resistance
10/16/2003US20030195167 Administering lovastain for treament of autoimmune diseases (rheumatoid arthritis)
10/16/2003US20030195164 Novel ribozyme and its use
10/16/2003US20030195156 Tumor necrosis factors; cytokines; immunoglobulins; autoimmune diseases
10/16/2003US20030195154 Comprises mimetics of erythropoietin, thrombopoietin, and glucagon-like peptide conjugated to polymer
10/16/2003US20030195149 Endozepine-like proteins, polynucleotides encoding them and methods of using the same
10/16/2003US20030195147 Identification of molecular structures, especially peptides, which are capable of acting at either insulin or insulin-like growth factor receptors as agonists or antagonists; treatment of diabetes
10/16/2003US20030194809 A DNA construct form an active recombinase protein in cell by intein-mediated trans-protein splicing; genetic transformation of organisms with foreign gene fragments; genetic engineering
10/16/2003US20030194808 Controlled electroporation and mass transfer across cell membranes
10/16/2003US20030194807 Walk-through mutagenesis
10/16/2003US20030194801 Use of flavivirus for the expression of protein epitopes and development of new live attenuated vaccine virus to immune against flavivirus and other infectious agents
10/16/2003US20030194800 For immunization, generation of packaging cell lines, and production of immunogenic compositions
10/16/2003US20030194798 For diagnositic, therapeutic, research, and drug discovery applications
10/16/2003US20030194797 Metalloproteinase ADAM 22
10/16/2003US20030194794 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 2398 2399 2400 2401 2402 2403 2404 2405 2406 2407 2408 2409 2410 2411 2412 2413 2414 2415 2416 2417 2418 ... 4023